We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Philip Morris

News List

Philip Morris International acquires OtiTopic expresspharma
August 11, 2021
This acquisition is part of PMI's strategic plan to leverage its expertise, scientific know-how and capabilities in inhalation to grow a pipeline of inhaled therapeutics and respiratory drug delivery Beyond Nicotine.
Philip Morris Heats Up Race for Vectura With $1.4 Billion Bid firstwordpharma
August 09, 2021
Philip Morris International on Sunday bid £1.65 per share for Vectura Group, after Carlyle on Friday offered £1.50 per share, Bloomberg reported.
Philip Morris agrees to acquire Vectura for $1.45bn pharmaceutical-technology
July 13, 2021
Philip Morris International (PMI) has made an offer to acquire a contract development and manufacturing organisation (CDMO), Vectura Group, for approximately $1.45bn (£1.045bn) to boost its product pipeline development expertise in inhaled treatments.